| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.35 | 0.05 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.56 | 0.05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |